- Home
- ASTI vs INM Comparison
ASTI vs INM Comparison
Compare ASTI & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASTI
- INM
- Stock Information
- Founded
- ASTI 2005
- INM 1981
- Country
- ASTI United States
- INM Canada
- Employees
- ASTI N/A
- INM N/A
- Industry
- ASTI Semiconductors
- INM Biotechnology: Pharmaceutical Preparations
- Sector
- ASTI Technology
- INM Health Care
- Exchange
- ASTI Nasdaq
- INM Nasdaq
- Market Cap
- ASTI 2.9M
- INM 3.2M
- IPO Year
- ASTI N/A
- INM N/A
- Fundamental
- Price
- ASTI $1.71
- INM $2.95
- Analyst Decision
- ASTI
- INM
- Analyst Count
- ASTI 0
- INM 0
- Target Price
- ASTI N/A
- INM N/A
- AVG Volume (30 Days)
- ASTI 34.7K
- INM 214.0K
- Earning Date
- ASTI 05-27-2025
- INM 05-27-2025
- Dividend Yield
- ASTI N/A
- INM N/A
- EPS Growth
- ASTI N/A
- INM N/A
- EPS
- ASTI N/A
- INM N/A
- Revenue
- ASTI $51,917.00
- INM $4,920,990.00
- Revenue This Year
- ASTI N/A
- INM N/A
- Revenue Next Year
- ASTI N/A
- INM N/A
- P/E Ratio
- ASTI N/A
- INM N/A
- Revenue Growth
- ASTI N/A
- INM N/A
- 52 Week Low
- ASTI $1.17
- INM $1.72
- 52 Week High
- ASTI $34.00
- INM $15.70
- Technical
- Relative Strength Index (RSI)
- ASTI 50.22
- INM 53.78
- Support Level
- ASTI $1.71
- INM $2.08
- Resistance Level
- ASTI $2.06
- INM $4.00
- Average True Range (ATR)
- ASTI 0.13
- INM 0.35
- MACD
- ASTI -0.00
- INM 0.01
- Stochastic Oscillator
- ASTI 23.91
- INM 45.31
About ASTI Ascent Solar Technologies Inc.
Ascent Solar Technologies Inc is engaged in the manufacturing, and selling of photovoltaic products (PV) solar modules that are flexible, durable, and possess attractive power-to-weight and power-to-area performance. The company is integrating its PV products into scalable and high-value markets such as agrivoltaics, aerospace, satellites, near-earth orbiting vehicles, and fixed-wing unmanned aerial vehicles (UAV). Ascent is also working to expand its portable solar chargers, such as the XD-12. The company markets and sells its products through OEMs, system integrators, distributors, retailers, and e-commerce companies.
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.